The Top Four Tips You Need to Prep For A Biotech IPO

capitalBiotech companies have fared well recently in the IPO market in both the US and the UK. New legislation in the US has eased access to public markets and the AIM market in London continues to be attractive for emerging biotech companies.

If you’re considering an IPO to raise capital for your biotech company, here are the four top tips you need to prep you on how to prepare for your big launch.

1. Intellectual property is key

Wrap up any and all Intellectual Property (IP) issues before kicking off an IPO process. Most advisors and investors are not as IP savvy as you and the key people in your company and will be spooked by the hint of any IP issues.

Wrinkles in IP licenses, outstanding options to acquire rights or potential threats to your IP from third parties are just a few of the issues that need to be bottomed out before the IPO. If not, you should have at least a crystal clear and lay explanation on hand to garner confidence among your advisors, solidify your valuation and most importantly, secure investors.

2. Set the structure

Early on in the process, ensure you line up tax and legal advisors you’re comfortable with and who cover all the global jurisdictions touched by both the IPO and by any share schemes.

It’s critical the tax advisors and legal advisors are aligned on the structure of your IPO framework including:

In what jurisdiction will the listing company be based?

Is a reorganization of the company’s structure required for tax efficiency and (crucially) how long will the legal steps of any such re-organization take?

Having an IPO structure that’s well considered from both a tax and legal perspective and complete (or near complete) in the early stages of an IPO should help avoid expensive and frustrating delays in the process.

3. Get the legal house in order

As in any exit transaction, substantial due diligence will be conducted on your company prior to an IPO. Ensure all your corporate documents and corporate secretarial matters are in order to smooth the process. Key individuals at the company should be available to assist in refining due diligence reviews and answer questions related to due diligence.

4. Keep management onside

Don’t underestimate the amount of work involved in an IPO. This can be hugely time-consuming and is often a new full time job for management, in addition to the work required for the successful operation of the business.

Have a dedicated IPO team within the Company – appoint key contacts for advisors and ensure consistent management participation in advisor meetings. Despite the huge range of characters you’ll have advising you on your IPO, from PR executives to lawyers to bankers, company management is key for driving the process. Regular insight and responsiveness from management ensures that your legal and other advisors can operate at top efficiency.

So, here are the key takeaways to prep for your biotech IPO:

  • Be prepared – get the house in order and leave no stone unturned. If you don’t turn it, someone else will!
  • Speak to advisers early. Pick the team and ensure you explore all structuring angles early.
  • Be financially prepared – an IPO is a costly exercise.
  • Have a dedicated internal team and ensure the business can function.

___

This post was co-written by James Shaw, Co-founder, JAG Shaw Baker and Karen Shike, Associate, Corporate, JAG Shaw Baker

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close